CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FRINGE proposes a novel cancer therapy that combines photomedical and neutron-based techniques to target deep tumors. By using specialized chemical agents that activate under neutron exposure, the project aims to enhance treatment efficacy while minimizing damage to surrounding tissues.
Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates.
In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue.
Current neutron-based therapies have sufficient penetration depth but suffer from lack of cancer specificity.
In FRINGE we propose a genuinely new hybrid-technology.
At its heart are chemical agents (photos…
OSLO UNIVERSITETSSYKEHUS HF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Agia Paraskevi
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, Girona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, Oslo
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Czechia, Praha
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
